Nevertheless, oAd-SA increased the anti-tumor activity of T cells as compared to oAd-ON, this was evidenced by upregulation of the ratio of IFN-γ-secreting CD4+, CD8+ T cells in spleen of mice treated with oAd-SA as compared to oAd-ON receiving animals. The gene discussed is CD4; the disease is neoplasm.